A GlaxoSmithKline logo is seen outside one of its buildings in west London.–Photo by Reuters

BOSTON: A US judge approved an agreement by British drug-maker GlaxoSmithKline to pay $3 billion for criminal and civil violations involving 10 drugs, the largest health care fraud settlement in US history.    

The amount of money involved led US District Judge Rya Zobel to remark in court that she was having trouble keeping track of the numbers.

GlaxoSmithKline pleaded guilty to promoting the popular antidepressants Paxil and Wellbutrin for unapproved uses.

Government officials said in the original complaint that the company promoted Paxil as safe for children and adolescents, even though the US Food and Drug Administration hadn't approved it for those patients and the company's clinical trials raised concerns about an increased suicide risk.

Prosecutors had charged that the drug-maker promoted Wellbutrin for unapproved uses that included treating attention deficit disorder, bipolar disorder, obesity, sexual dysfunction and anxiety when it wasn't shown to be safe and effective for those uses.

The company also admitted that it failed to report to the government some safety problems with Avandia. In 2010, the diabetes drug was restricted in the US and banned in Europe after it was found to sharply increase the risks of heart attacks and congestive heart failure. Defense lawyer Geoffrey Hobart and Assistant US Attorney Sara Bloom declined to comment immediately following Thursday's hearing.

A GlaxoSmithKline spokesman referred later to comments CEO Sir Andrew Witty made, including that the company has learned ''from the mistakes that were made.''

When the government announced the settlement, US Deputy Attorney General James M. Cole called it historic, saying it sent a clear warning to any company that chooses to break the law.

More From This Section

Dar’s statement helps dollar gain 1pc

Dar’s statement that the dollar will be kept around Rs98 to support the export industry created panic-like situation.

Ecnec okays Rs62bn projects

The Executive Committee of the National Economic Council has approved Rs62 billion worth of development projects.

Cotton output rises to 13.39m bales

Figures compiled by CGA, Aptma and KCA during outgoing fortnight show around 4,953 cotton bales reached ginning units.

OICCI seeks integrated tax collection

The OICCI has asked Sindh to integrate all revenue collection under one roof and also raise tax from agriculture sector.


Comments are closed.

Comments (4)

ali
July 13, 2012 4:57 pm
GSK has made more than billions before the FDA checked them and put fine. Its too little too late. All govt. agencies are same in their speed.
dilawer
July 6, 2012 7:40 am
Improve your reporting. You Newspaper is full of spelling mistakes and incorrect reporting. Make comments section available under each news so people can correct mistakes.
AHKHAN
July 6, 2012 7:41 am
If they do this in USA .One could Imagine how much havoc they would have played with patients in our area .All these drugs are being used in Pakistan .
amna
July 8, 2012 5:21 am
thanks DAWN for bringing such an important news to readers
Explore: Indian elections 2014
Explore: Indian elections 2014
How much do you know about Indian Elections?
How much do you know about Indian Elections?
Poll
From The Newspaper
Tweets